by John A. Jenkins | Sep 11, 2024 | FDA, FOIA, FTC, SEC
FOIAengine Explores the Widespread Use of “Neither Confirm Nor Deny” By John A. Jenkins We’re taking a look this week at a frequently used Freedom of Information Act exemption that isn’t mentioned anywhere in the statutory language. It’s known as “Glomar” among the...
by John A. Jenkins | Sep 4, 2024 | FOIA, Politics, SEC
FOIAengine: DNC’s Five Requests Also Target Nominee’s Venture Capital Partners Caroline Graham is the Democratic National Committee’s research director, a $144,000-a-year job that puts her on the front line of gathering dirt on the Republican vice-presidential...
by Randy E. Miller | Aug 21, 2024 | Antitrust, Cryptocurrency, FOIA, FTC, News Media
FOIAengine Analysis Reveals Targets and Topics News media outlets continued to be the leading submitters of Freedom of Information Act requests to the Federal Trade Commission during the first half of 2024, with many of the requests focused on the agency’s...
by John A. Jenkins | Aug 14, 2024 | FOIA, Litigation, News Media, SEC, Short-Selling
FOIAengine: How the “Bounty Hunter of Wall Street” Hedged His Bets As a young man, Andrew Left was a “real serious kid” – and very religious. He wanted to be a rabbi. But then, in his telling, Left saw a newspaper ad that said, “Earn $100,000.” “I thought, ‘Yeah,...
by John A. Jenkins | Jul 30, 2024 | Antitrust, FOIA, FTC, Law Firms, Pharmaceuticals
FOIA Requests Target Scott Sheffield, King of the Frackers, Amid Reports of a Criminal Referral This week, we’re looking into how antitrust enforcers used their approval of an oil-industry megadeal to send a message about white-collar criminality. It’s a cautionary...
by Randy E. Miller | Jul 24, 2024 | FOIA, FTC, Medical Devices, Pharmaceuticals
FOIAengine Reveals Inquiries About FTC’s Inner Workings With the Federal Trade Commission reportedly preparing to sue the three largest pharmacy benefit managers, or PBMs, over their approach to negotiating the availability and prices for drugs, we’re taking a look...
